Aeglea BioTherapeutics Doses First Patient in Phase 3 Trial of Pegzilarginase in Arginase 1 Deficiency Biotech Investing
Ceapro Starts Patient Enrollment in First-in-Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent Biotech Investing
Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD Cannabis Investing News
Life Science Big News Roundup: Cardiol Commences Trading on the OTCQX; Combining Lexaria’s DehydraTECH(TM) with Nanotech Delivers Increased Quantities of CBD into Brain Tissue; BriaCell’s Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Life Science Investing News
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments Biotech Investing
Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial Pharmaceutical Investing
